Audentes Therapeutics, Inc.
DelistedCIK 1628738fmd_08B00Z6RG81NSGS82G7F8FZK9ZManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard
Coverage: Jan 01, 2014 to Sep 30, 2019, 20 periods
| Line item | FY2014 | FY2015 | FY2016 | FY2017 | FY2018 |
|---|---|---|---|---|---|
| Research and development | 9 | 20 | 49 | 76 | 104 |
| Total operating expenses | 11 | 27 | 60 | 93 | 134 |
| Operating income | (11) | (27) | (60) | (93) | (134) |
| Interest and investment income | 0 | 0 | 0 | – | – |
| Other non-operating income (expense) | 0 | 0 | (0) | (0) | (0) |
| Income before taxes | – | (26) | (60) | (92) | (129) |
| Income tax expense | – | – | – | (2) | – |
| Net income from continuing operations | – | – | – | (90) | – |
| Net income | (11) | (26) | (60) | (90) | (129) |